Company Comparison
Oryzon Genomics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Oryzon Genomics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Barcelona, Spain | Lagos, Nigeria |
| Founded | 2000 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $50M | $45M |
| Valuation | — | — |
What They Build
Oryzon Genomics
Spanish biopharmaceutical company developing epigenetic therapies for cancer and CNS diseases using histone deacetylase and lysine demethylase inhibitors.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Oryzon Genomics
Sector Overlap
Both Oryzon Genomics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.